179 related articles for article (PubMed ID: 21130800)
1. Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice.
Seminerio MJ; Kaushal N; Shaikh J; Huber JD; Coop A; Matsumoto RR
Pharmacol Biochem Behav; 2011 Mar; 98(1):12-20. PubMed ID: 21130800
[TBL] [Abstract][Full Text] [Related]
2. σ Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation.
Robson MJ; Seminerio MJ; McCurdy CR; Coop A; Matsumoto RR
Pharmacol Rep; 2013; 65(2):343-9. PubMed ID: 23744418
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: Evidence from in vivo and in vitro studies.
Matsumoto RR; Shaikh J; Wilson LL; Vedam S; Coop A
Eur Neuropsychopharmacol; 2008 Dec; 18(12):871-81. PubMed ID: 18755577
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo.
Kaushal N; Seminerio MJ; Robson MJ; McCurdy CR; Matsumoto RR
Eur Neuropsychopharmacol; 2013 Aug; 23(8):960-71. PubMed ID: 22921523
[TBL] [Abstract][Full Text] [Related]
5. CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice.
Kaushal N; Seminerio MJ; Shaikh J; Medina MA; Mesangeau C; Wilson LL; McCurdy CR; Matsumoto RR
Neuropharmacology; 2011; 61(5-6):992-1000. PubMed ID: 21762711
[TBL] [Abstract][Full Text] [Related]
6. AC927, a σ receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells.
Kaushal N; Elliott M; Robson MJ; Iyer AK; Rojanasakul Y; Coop A; Matsumoto RR
Mol Pharmacol; 2012 Mar; 81(3):299-308. PubMed ID: 22101517
[TBL] [Abstract][Full Text] [Related]
7. Effects of the selective sigma receptor ligand, 1-(2-phenethyl)piperidine oxalate (AC927), on the behavioral and toxic effects of cocaine.
Matsumoto RR; Li SM; Katz JL; Fantegrossi WE; Coop A
Drug Alcohol Depend; 2011 Oct; 118(1):40-7. PubMed ID: 21420799
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of AZ66, an optimized sigma receptor antagonist, against methamphetamine-induced dopaminergic neurotoxicity and memory impairment in mice.
Seminerio MJ; Hansen R; Kaushal N; Zhang HT; McCurdy CR; Matsumoto RR
Int J Neuropsychopharmacol; 2013 Jun; 16(5):1033-44. PubMed ID: 22932447
[TBL] [Abstract][Full Text] [Related]
9. M100907 and BD 1047 attenuate the acute toxic effects of methamphetamine.
Ray A; Canal CE; Ehlen JC; Rice KC; Murnane KS
Neurotoxicology; 2019 Sep; 74():91-99. PubMed ID: 31163210
[TBL] [Abstract][Full Text] [Related]
10. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
Broening HW; Morford LL; Vorhees CV
Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
[TBL] [Abstract][Full Text] [Related]
11. Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1β mRNA expression in the hypothalamus.
Seminerio MJ; Robson MJ; McCurdy CR; Matsumoto RR
Eur J Pharmacol; 2012 Sep; 691(1-3):103-9. PubMed ID: 22820108
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro.
Kaushal N; Robson MJ; Rosen A; McCurdy CR; Matsumoto RR
Eur J Pharmacol; 2014 Feb; 724():193-203. PubMed ID: 24380829
[TBL] [Abstract][Full Text] [Related]
13. nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice.
Itzhak Y; Martin JL; Ail SF
Neuroreport; 2000 Sep; 11(13):2943-6. PubMed ID: 11006970
[TBL] [Abstract][Full Text] [Related]
14. A comparison of methylphenidate-, amphetamine-, and methamphetamine-induced hyperthermia and neurotoxicity in male Sprague-Dawley rats during the waking (lights off) cycle.
Levi MS; Divine B; Hanig JP; Doerge DR; Vanlandingham MM; George NI; Twaddle NC; Bowyer JF
Neurotoxicol Teratol; 2012 Mar; 34(2):253-62. PubMed ID: 22289608
[TBL] [Abstract][Full Text] [Related]
15. SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation.
Robson MJ; Turner RC; Naser ZJ; McCurdy CR; O'Callaghan JP; Huber JD; Matsumoto RR
Exp Neurol; 2014 Apr; 254():180-9. PubMed ID: 24508558
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of methamphetamine-induced nigrostriatal dopaminergic neurotoxicity in mice by lipopolysaccharide pretreatment.
Lin YC; Kuo YM; Liao PC; Cherng CG; Su SW; Yu L
Chin J Physiol; 2007 Apr; 50(2):51-6. PubMed ID: 17608141
[TBL] [Abstract][Full Text] [Related]
17. Reduction of nuclear peroxisome proliferator-activated receptor gamma expression in methamphetamine-induced neurotoxicity and neuroprotective effects of ibuprofen.
Tsuji T; Asanuma M; Miyazaki I; Miyoshi K; Ogawa N
Neurochem Res; 2009 Apr; 34(4):764-74. PubMed ID: 18946735
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters.
Numachi Y; Ohara A; Yamashita M; Fukushima S; Kobayashi H; Hata H; Watanabe H; Hall FS; Lesch KP; Murphy DL; Uhl GR; Sora I
Eur J Pharmacol; 2007 Oct; 572(2-3):120-8. PubMed ID: 17673199
[TBL] [Abstract][Full Text] [Related]
19. The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
Terleckyj I; Sonsalla PK
J Pharmacol Exp Ther; 1994 Apr; 269(1):44-50. PubMed ID: 7513362
[TBL] [Abstract][Full Text] [Related]
20. Effect of 7-nitroindazole on body temperature and methamphetamine-induced dopamine toxicity.
Callahan BT; Ricaurte GA
Neuroreport; 1998 Aug; 9(12):2691-5. PubMed ID: 9760103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
